Characterisation of the effects of SR146131, a novel non-peptide CCK1 receptor agonist, on IMR-32 human neuroblastoma cells
Paul Schaeffer(Universidad La Salle), Jean Marc Herbert(Sanofi (France)), V. Prabonnaud(Sanofi (France)), Eric Bignon(Sanofi (France)), Albiñana Néstor(Sanofi (France)), Marie-Claude Laplace(Sanofi (France)), P.E. Keane(Sanofi (France)), André Bachy(Sanofi (France))
Cited by 4
Related Papers
PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis
|PLoS Biology|2005|943
PGC-1α Coactivates PDK4 Gene Expression via the Orphan Nuclear Receptor ERRα: a Mechanism for Transcriptional Control of Muscle Glucose Metabolism
|Molecular and Cellular Biology|2005|355
The Lectin-like Domain of Thrombomodulin Confers Protection from Neutrophil-mediated Tissue Damage by Suppressing Adhesion Molecule Expression via Nuclear Factor κB and Mitogen-activated Protein Kinase Pathways
|The Journal of Experimental Medicine|2002|349
Transcriptional coactivators PGC-1α and PGC-lβ control overlapping programs required for perinatal maturation of the heart
|Genes & Development|2008|325
Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy
|Journal of Clinical Investigation|2005|260